Melanoma testing

A new test finds melanoma early and without cutting

Melanoma is the deadliest of skin cancers. The average age of patients diagnosed with melanoma is 63, but today it is also one of the most common types of cancer in young adults in North America. Since 2007, the US Food and Drug Administration (FDA) and Canadian authorities have approved over 10 new types of treatment for late-stage melanoma, but by far the best outcome for melanoma patients comes from detecting their skin cancer early. A new non-invasive test (is termed Pigmented Lesion Assay) to help detect melanoma early and without cutting has just became available in Canada. It has been used successfully in the US for over 2 years. The Pigmented Lesion Assay uses adhesive patches to collect skin sample of areas suspicious for melanoma and looks at molecular risk factors rather than morphological changes under the microscope. 

Advantages:

  • Finds melanoma in early stage.

  • Without any cutting on the skin

  • Reduces the risk of missing melanomas 

  • More accurate than inspection by a physician

  • Fast and convenient

Contact Us

Our clinic is located at 1711 West Broadway, Vancouver, BC. Please call us at 604-670-0400 for a complementary consultation.

error: Content is protected !!